182 related articles for article (PubMed ID: 18210732)
1. [New pathophysiological concepts in pulmonary hypertension in COPD].
Firă-Mladinescu O; Tudorache V; Mihăicuţă S; Cristescu A
Pneumologia; 2003; 52(3-4):188-92. PubMed ID: 18210732
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in COPD: old and new concepts.
Barberà JA; Peinado VI; Santos S
Monaldi Arch Chest Dis; 2000 Dec; 55(6):445-9. PubMed ID: 11272628
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review.
Wrobel JP; Thompson BR; Williams TJ
J Heart Lung Transplant; 2012 Jun; 31(6):557-64. PubMed ID: 22502811
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Gologanu D; Stanescu C; Bogdan MA
Rom J Intern Med; 2012; 50(4):259-68. PubMed ID: 23610973
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in chronic obstructive pulmonary disease.
Barberà JA; Peinado VI; Santos S
Eur Respir J; 2003 May; 21(5):892-905. PubMed ID: 12765440
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.
Wright JL; Levy RD; Churg A
Thorax; 2005 Jul; 60(7):605-9. PubMed ID: 15994270
[TBL] [Abstract][Full Text] [Related]
7. Is systemic inflammation responsible for pulmonary hypertension in COPD?
Sin DD; Man SF
Chest; 2006 Aug; 130(2):310-2. PubMed ID: 16899824
[No Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosus.
Tanaseanu C; Tudor S; Tamsulea I; Marta D; Manea G; Moldoveanu E
Eur J Med Res; 2007 Apr; 12(4):145-51. PubMed ID: 17509958
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.
Zakynthinos E; Daniil Z; Papanikolaou J; Makris D
Curr Drug Targets; 2011 Apr; 12(4):501-13. PubMed ID: 21194405
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
Barberà JA; Blanco I
Drugs; 2009 Jun; 69(9):1153-71. PubMed ID: 19537834
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in advanced chronic obstructive pulmonary disease.
Orr R; Smith LJ; Cuttica MJ
Curr Opin Pulm Med; 2012 Mar; 18(2):138-43. PubMed ID: 22189454
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vasculature in COPD: The silent component.
Blanco I; Piccari L; Barberà JA
Respirology; 2016 Aug; 21(6):984-94. PubMed ID: 27028849
[TBL] [Abstract][Full Text] [Related]
13. [Some mechanisms of pulmonary hypertension development in patients with chronic obstructive pulmonary diseases].
Karoli NA; Rebrov AP
Ter Arkh; 2005; 77(3):87-93. PubMed ID: 15881111
[No Abstract] [Full Text] [Related]
14. [Pulmonary hypertension and cor pulmonale in COPD].
Kuwahira I; Iwamoto T
Nihon Rinsho; 2003 Dec; 61(12):2138-43. PubMed ID: 14674323
[TBL] [Abstract][Full Text] [Related]
15. Right heart function in COPD.
Macnee W
Semin Respir Crit Care Med; 2010 Jun; 31(3):295-312. PubMed ID: 20496299
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: recent advances in pathophysiology and management.
Hida W; Tun Y; Kikuchi Y; Okabe S; Shirato K
Respirology; 2002 Mar; 7(1):3-13. PubMed ID: 11896895
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
Weitzenblum E; Chaouat A; Canuet M; Kessler R
Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
[TBL] [Abstract][Full Text] [Related]
18. [Secondary pulmonary hypertension: some aspects of pathogenesis].
Ter Arkh; 2012; 84(3):22-8. PubMed ID: 22708418
[TBL] [Abstract][Full Text] [Related]
19. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
Corte TJ; Wort SJ
Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease.
Naeije R
Proc Am Thorac Soc; 2005; 2(1):20-2. PubMed ID: 16113464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
